Enzystal

Contraindications

Hypersensitivity, biliary obstruction, jaundice.

Incompatibilities

Cimetidine, antacids enhance the effect. Reduces the bioavailability of iron preparations.

Pharmaceutical form

White, round, biconvex tablets, covered with a sugar coating.

Undesirable effects

Nausea, spastic abdominal pain, diarrhea, pain in the mouth and anal area (in children), increased uric acid concentration in the blood and urine, allergic reactions (sneezing, lacrimation, urticaria, bronchospasm).

Therapeutic indications

Insufficiency of the external secretory function of the pancreas in cystic fibrosis, chronic pancreatitis, after pancreatectomy, when the pancreatic duct is compressed by a tumor, steatorrhea in malabsorption syndrome, conditions after gastroectomy, dyspepsia in case of errors in nutrition, in chronic diseases of the digestive system (especially in the elderly) and in patients on long-term bed rest, preparation for X-ray and ultrasound examination of the abdominal cavity.

Pharmacotherapeutic group

  • Enzymes and antiferments in combinations

Pharmacodynamic properties

Improves the functional state of the gastrointestinal tract and normalizes digestion, helps to cleanse the intestines of contents and gases.

Special precautions for storage

In a dry place, protected from light, at a temperature not exceeding 25 °C.

Keep out of reach of children.

Shelf life of the drug Enzistal®3 года.

Do not use after the expiration date indicated on the package.

Nature and contents of container

Tablets, coated with a shell, soluble in the intestine 1 table.
pancreatin 192 mg
(which corresponds to 6000 units (FIP) of lipase, 4500 units of amylase, 300 units of protease)  
hemicellulase 50 mg
bovine bile extract 25 mg
excipients: lactose, magnesium stearate, silicon dioxide colloidal, cellulose acetate phthalate, diethyl phthalate, sugar, calcium carbonate, talc, arabian gum, gelatin, titanium dioxide, beeswax, carnauba wax  

in a blister pack of 10 pcs. , in a pack of cardboard 2 or 8 blisters.

Nosological classification (ICD-10)

  • E16. 9 Violation of the internal secretion of the pancreas, unspecified
  • E61 Insufficiency of other batteries
  • E84. 1 Cystic fibrosis with intestinal manifestations
  • K29 Gastritis and duodenitis
  • K29. 5 Chronic gastritis, unspecified
  • K30 Dyspepsia
  • K52 Other non-infectious gastroenteritis and colitis
  • K81 Cholecystitis
  • K86. 1 Other chronic pancreatitis
  • K86. 8. 0 * External pancreatic hypofunction
  • K87. 0 Damage to the gallbladder and biliary tract in diseases classified elsewhere
  • K90. 3 Pancreatic steatorrhea
  • K92. 9 Digestive system disease, unspecified
  • K94 * Diagnosis of gastrointestinal diseases
  • R14 Flatulence and related conditions
  • Z72. 4 Unacceptable diet and bad eating habits
  • Z98. 8 Other specified post-surgical conditions

Dosage (Posology) and method of administration

Inside, without chewing, during or immediately after a meal, with a small amount of liquid.

Adults — 1-2 tablets 3 times a day. Higher doses are prescribed by a doctor. Children over 6 years of age (as prescribed by a doctor) - 1 table 2-3 times a day.

The duration of treatment can vary from several days (in case of digestive disorders due to errors in the diet) to several months or years (if permanent replacement therapy is required).

Before X-ray examination or ultrasound — 2 tables. 2-3 times a day for 2-3 days before the study.

ATC - Anatomical and therapeutic chemical classification

A09A Digestive-promoting drugs, including enzyme preparations